Healthtech Series A Investors & VC Firms
2310 firms in this list, with a median first check of $500K. 550 of them lead rounds. Generated from verified public data and updated continuously.
Pfizer Venture Investments
Seed–Late Stage$5M – $20M
16 people
Acon Investments
WashingtonSeed–Growth
39 people
Taiwania Capital
TaipeiSeed–Growth
49 people
Lightstone Ventures
Portola ValleyPre-Seed–Series C
31 people
Presidio Ventures
Silicon ValleySeed–Growth$500K – $5M
26 people
Underscore VC
BostonPre-Seed–Series A
34 people
Illumina Ventures
Foster CitySeed–Series A
40 people
redalpine
ZugSeed–Growth$108K – $2.2M
28 people
ACME Capital
San FranciscoPre-Seed–Growth
13 people
b2venture
BerlinPre-Seed–Series B$270K – $5.4M
36 people
OMERS Ventures
TorontoPre-Seed–Series C$5M – $25M
15 people
Sanofi Ventures
CambridgeSeed–Series B$5M
20 people
M Ventures
AmsterdamSeed–Growth$10.8M
12 people
Bluepoint Partners
DaejeonPre-Seed–Series A
50 people
SR One Capital Management
Redwood CitySeed–Series B
30 people
GTMfund
ScottsdalePre-Seed–Series A$1M – $3M
16 people
Lifeline Ventures
HelsinkiPre-Seed–Series A
13 people
Eurazeo
ParisSeed–Late Stage
35 people
OneVentures
SydneySeed–Growth$3.3M – $13.2M
40 people
Coral Capital
TokyoPre-Seed–Growth$500K – $5M
24 people
Arboretum Ventures
Ann ArborSeed–Series A$5M – $15M
28 people
Silverton Partners
AustinPre-Seed–Series A$200K – $2M
10 people
Olive Tree Capital
BostonSeed–Growth
6 people
Vertex Ventures Israel
Tel Aviv-YafoSeed–Series B$1M – $10M
17 people
Related lists
Series A Investors & VC Firms (7326)Series A Investors & VC Firms in North America (4220)Healthtech Investors & VC Firms (4191)Series A Investors & VC Firms in United States (3839)Healthtech Seed Investors & VC Firms (3233)Healthtech Investors & VC Firms in North America (2666)AI & Machine Learning Series A Investors & VC Firms (2601)SaaS Series A Investors & VC Firms (2591)Healthtech Investors & VC Firms in United States (2437)Series A Investors & VC Firms in Europe (2384)
Data sourced from public filings and firms' own websites — see our methodology.











































































































